Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin

por Schwartz, Stanley S
Publicado 2010

Optimizing glycemic control and minimizing the risk of hypoglycemia in patients with type 2 diabetes

por Schwartz, Stanley S
Publicado 2013

MON-618 A Framework for Understanding and Managing ‘The Diabetes Syndrome’: A Unified Pathophysiologic Approaching the Context of the Beta-Cell Classification of Diabetes

por Schwartz, Stanley S
Publicado 2020

Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin

por Schwartz, Stanley S, Katz, Arie
Publicado 2016

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies

por Schwartz, Stanley, Kohl, Benjamin A
Publicado 2010

Diabetic Retinopathy–An Underdiagnosed and Undertreated Inflammatory, Neuro-Vascular Complication of Diabetes

por Sinclair, Stephen H., Schwartz, Stanley S.
Publicado 2019

Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?: The time has come for GLP-1 receptor agonists!

por Schwartz, Stanley, DeFronzo, Ralph A.
Publicado 2013

Mucosal immunity: The immunology of breast milk

por Slade, Herbert B., Schwartz, Stanley A.
Publicado 1987

An evidence-based practice-oriented review focusing on canagliflozin in the management of type 2 diabetes

por Messana, Joseph A, Schwartz, Stanley S, Townsend, Raymond R
Publicado 2017

The Diabetes Syndrome – A Collection of Conditions with Common, Interrelated Pathophysiologic Mechanisms

por Rachfal, Amy W, Grant, Struan F A, Schwartz, Stanley S
Publicado 2021

Immunological assays for chemokine detection in in-vitro culture of CNS cells

por Mahajan, Supriya D., Schwartz, Stanley A., Nair, Madhavan P.N.
Publicado 2003

Diabetes and Psoriasis: Different Sides of the Same Prism

por Abramczyk, Rachel, Queller, Jenna N, Rachfal, Amy W, Schwartz, Stanley S
Publicado 2020

LBSUN211 The Importance Of Early Opportunities To Identify And Treat Prediabetes Or Even Change The Diagnostic Threshold For Diabetes

por Schwartz, Stanley S, Larson, Sharon, Kjelstrom, Stephanie, Beaupre, Justin, Hartz, William
Publicado 2022

PO262 / #255 NEUROMODULATORY EFFECTS OF SARS-COV2 ON BLOOD BRAIN BARRIER INTEGRITY AND FUNCTION: E-POSTER VIEWING

por Clough, Erin, Chaves, Lee, Aalinkeel, Ravikumar, Schwartz, Stanley, Reynolds, Jessica, Mahajan, Supriya
Publicado 2022

Combination Modality Using Quercetin to Enhance the Efficacy of Docetaxel in Prostate Cancer Cells

por Sharma, Satish, Cwiklinski, Katherine, Mahajan, Supriya D., Schwartz, Stanley A., Aalinkeel, Ravikumar
Publicado 2023

Microbial Biofilm: A Review on Formation, Infection, Antibiotic Resistance, Control Measures, and Innovative Treatment

por Sharma, Satish, Mohler, James, Mahajan, Supriya D., Schwartz, Stanley A., Bruggemann, Liana, Aalinkeel, Ravikumar
Publicado 2023

Angioedema in African American Patients Hospitalized for COVID-19

por Batarseh, Einas, Kersten, Brian P., Pinelo, Anna C., Nadler, Jamie N., Schwartz, Stanley A.
Publicado 2020

Effector cell mediated cytotoxicity measured by intracellular Granzyme B release in HIV infected subjects

por Mahajan, Supriya D., Aalinkeel, Ravikumar, Schwartz, Stanley A., Chawda, Ram P., Nair, Madhavan P.N.
Publicado 2003

Reply to Chan and Majluf-Cruz: Is the Angioedema Associated with COVID-19 a Real Entity, a Mimic, or Both?

por Batarseh, Einas, Kersten, Brian P., Pinelo, Anna C., Vertalino, Vincent, Nadler, Jamie N., Schwartz, Stanley A.
Publicado 2021

Use of Glycoproteins—Prostate-Specific Membrane Antigen and Galectin-3 as Primary Tumor Markers and Therapeutic Targets in the Management of Metastatic Prostate Cancer

por Sharma, Satish, Cwiklinski, Katherine, Sykes, Donald E., Mahajan, Supriya D., Chevli, Kent, Schwartz, Stanley A., Aalinkeel, Ravikumar
Publicado 2022